Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder is a group of mood disorders characterized by distinct episodes of altered mood, energy, activity, sleep, and behavior. An episode may involve mania, hypomania, depression, or combinations of symptoms. These changes differ from ordinary emotional fluctuations in duration, intensity, associated activation, and consequences for functioning. Bipolar I disorder, bipolar II disorder, cyclothymic disorder, and other specified or unspecified bipolar presentations have distinct diagnostic criteria. Effective care combines accurate assessment, phase-specific treatment, long-term monitoring, and support for the person's own recovery goals. National Institute of Mental Health | WHO
A diagnosis cannot be made from someone being energetic one day and sad the next, a single episode of impulsive behavior, or the result of an online questionnaire. Clinicians examine a lifetime pattern of sustained mood-and-energy changes, especially previous periods of mania or hypomania. The distinction matters because treatment of acute mania, bipolar depression, and prevention of recurrence has different evidence and safety requirements. VA/DoD bipolar disorder guideline (2023)
For additional clinical context, see Types of Bipolar Disorder: Bipolar I, Bipolar II, Cyclothymia, and Other Forms and Bipolar I Disorder: Symptoms, Diagnosis, and Treatment.
What Is Bipolar Disorder?
Bipolar disorder concerns episodes during which a person's mood and level of activation change noticeably from their usual baseline. Activation includes energy, goal-directed behavior, movement, speech, ideas, and need for sleep. An elevated or irritable episode may involve unusual confidence, racing thoughts, intense activity, and risky decisions. A depressive episode may involve loss of interest, low energy, reduced concentration, changes in sleep or appetite, and feelings of hopelessness. The person may have periods of relative stability between episodes, sometimes lasting months or years. NIMH
The word “bipolar” refers to different poles of mood episodes, but individual courses are more varied than a simple alternation between happiness and sadness. Some people experience mostly depression, some have prominent episodes of mania, and some have mixed features. Mood symptoms may remain between episodes. Clinical care therefore examines both the current condition and the longitudinal course. “Manic depression” is an older term; contemporary classifications identify specific bipolar and related disorders.
The condition can affect educational progress, employment, finances, family relationships, physical health, and personal safety. Its impact depends on the episode, access to care, medical conditions, social support, and recovery circumstances. With appropriate care, many people experience sustained stability and pursue meaningful personal and professional lives. WHO
Types of Bipolar Disorder
Bipolar I disorder
Bipolar I disorder is defined by at least one lifetime manic episode, after clinicians assess whether substances, medications, or medical illness better explain it. A manic episode generally lasts at least one week and occupies most of the day nearly every day. A shorter duration can qualify when hospitalization is required. Mania involves marked impairment, hospitalization because of its severity, or psychotic features. A major depressive episode is common in bipolar I but is not required for the diagnosis. NIMH | VA/DoD
A person may initially seek care for depression and remember a manic episode only after careful questioning. The existence of full mania changes the diagnostic category, the treatment considerations, and the approach to relapse prevention. Mania can be predominantly irritable and agitated rather than joyful. Severe disruption of judgment or an inability to maintain basic safety may require urgent specialist evaluation.
Bipolar II disorder
Bipolar II disorder involves at least one major depressive episode and at least one hypomanic episode, without a history of full mania. Hypomania is a sustained, recognizable change from a person's ordinary mood and energy, observable by others, but it does not involve the marked impairment, hospitalization for episode severity, or psychotic symptoms that distinguish mania. The depressive episodes of bipolar II can be recurrent and highly disabling. Bipolar II is a distinct illness, not a uniformly mild version of bipolar I. NIMH | CANMAT/ISBD 2023 update
Hypomania may feel productive or enjoyable. People sometimes describe these periods as simply having more energy than usual. A clinician asks whether the change was sustained, unusual for that individual, accompanied by several characteristic symptoms, and noticeable to people who knew them. A past episode with psychosis or marked manic impairment changes the diagnostic picture.
Cyclothymic disorder
Cyclothymic disorder involves numerous periods with hypomanic symptoms and numerous periods with depressive symptoms that do not meet the full criteria for corresponding episodes during the relevant diagnostic period. In adults this pattern extends for at least two years; in children and adolescents, at least one year, with additional requirements regarding persistence and symptom-free intervals. The disorder is assessed through the entire course rather than a single good or bad week. The symptoms may still interfere with relationships, work, and wellbeing. NIMH
Other specified and unspecified bipolar and related disorders
Other specified bipolar and related disorder is used for clinically significant presentations that do not meet complete criteria for the better-defined categories, with the reason specified. Unspecified bipolar and related disorder may be used when available information is insufficient or the clinician does not specify the reason. Both require thoughtful clinical evaluation. “Bipolar spectrum” is used variably in research and some clinical discussions, but it is not an additional standalone diagnosis established by that phrase alone. NIMH
Symptoms of Mania
A manic episode combines an abnormally elevated, expansive, or irritable mood with abnormally increased activity or energy and a characteristic cluster of changes. Common manifestations include decreased need for sleep; speaking more or faster than usual; racing thoughts or rapidly changing ideas; increased distractibility; unusually high confidence or grandiosity; increased goal-directed projects or psychomotor agitation; and risky activities such as uncontrolled spending, dangerous driving, or uncharacteristic sexual decisions. Symptoms must be understood in their clinical context and evaluated for impairment. NIMH
Reduced need for sleep is especially informative when someone sleeps very little yet feels fully energetic. Ordinary insomnia often involves fatigue and distress about inadequate sleep. The distinction is not absolute, and a sleep pattern alone does not diagnose mania. Some manic episodes are accompanied by delusions or hallucinations. Severe mania may compromise the ability to make decisions, manage money, eat regularly, or avoid dangerous situations. Rapid evaluation is appropriate when judgment, safety, or reality testing are impaired.
Mania is not synonymous with enthusiasm, ambition, or a naturally outgoing personality. The clinician looks for an episode that represents a change in the person's baseline, meets characteristic duration and severity thresholds, and has relevant functional consequences.
Symptoms of Hypomania
Hypomania involves many of the same types of symptoms as mania but differs in severity and consequences. The characteristic episode lasts at least four consecutive days, for most of the day, nearly every day. Mood and activity must be clearly different from the person's ordinary state, and the change must be noticeable to others. A hypomanic episode does not, by definition, produce marked functional impairment, require hospitalization because of its severity, or include psychosis. If psychotic features occur during an elevated episode, that episode is manic. SAMHSA DSM-5 criteria comparison
Hypomania can still affect decisions and relationships. It may precede severe depression or lead someone to take on more responsibilities than they can sustain. It can also be missed in an interview because the person remembers feeling well. A careful history may include input from a partner or trusted relative, with appropriate consent.
Symptoms of Bipolar Depression
A major depressive episode lasts at least two weeks and typically includes depressed mood or loss of interest or pleasure, together with additional symptoms such as low energy, difficulty concentrating, appetite or weight change, insomnia or excessive sleep, psychomotor slowing or agitation, guilt or worthlessness, and thoughts of death. Severity and impairment vary. Depressive symptoms can resemble those in major depressive disorder; the bipolar diagnosis depends on lifetime episodes of mania or hypomania and the clinical differential. NIMH
Some people with bipolar disorder experience more days of depression than of mania or hypomania. This makes a lifetime history important: an assessment limited to the current depressive symptoms may overlook elevated episodes. The presence of anxiety, agitation, or sleep disturbance during depression does not, by itself, prove mixed features or bipolarity.
Mixed Features, Rapid Cycling, and Psychosis
“Mixed features” is an episode specifier indicating that an episode of mania, hypomania, or depression also contains a defined number of symptoms associated with the opposite mood pole. A person may feel intensely activated while also experiencing painful depressive thoughts. Mixed states can complicate medication selection and may intensify distress or impulsivity. They deserve specific clinical evaluation, including safety and suicide-risk assessment. CANMAT/ISBD
“Rapid cycling” means at least four qualifying mood episodes in a 12-month period, with episode boundaries determined by accepted criteria. It is not a clinical synonym for feeling different emotions over several hours. The number, length, sequence, and separation of episodes should be documented carefully, along with medication and substance exposure. NIMH
Psychotic features, such as hallucinations or delusions, may occur in severe manic or depressive episodes. Psychosis associated with bipolar disorder requires careful assessment of when these symptoms appear relative to mood episodes. Psychotic symptoms lasting independently of mood episodes can change the differential diagnosis. Acute confusion, threatening behavior, or an inability to maintain safety warrants emergency evaluation. NIMH
How Long Do Bipolar Episodes Last?
Clinical episode thresholds guide diagnosis: mania usually lasts at least seven days or any duration requiring hospitalization; hypomania at least four consecutive days; and major depression at least two weeks. Actual episodes may extend well beyond these minimums. Some individuals experience prolonged residual symptoms, while others return to their usual functioning between episodes. NIMH | SAMHSA
Remission describes a major reduction or absence of episode-level symptoms. Euthymia refers to a comparatively stable mood state. Both can coexist with ongoing sleep, concentration, anxiety, or functional problems. Recovery encompasses health, relationships, purpose, and everyday functioning, not only whether diagnostic criteria are met on a particular day. Recording episodes longitudinally supports more accurate treatment choices.
Causes and Risk Factors
Bipolar disorders arise from interacting genetic, biological, developmental, and environmental influences. Family history is an important risk factor, but it does not determine a person's future. No single genetic variant, neurotransmitter, brain scan, trauma history, or stressful event identifies a definitive cause in all patients. Research examines reward systems, emotion processing, cognition, sleep–wake rhythms, and other biological processes, but these group-level findings do not provide a routine individual diagnostic test. NIMH
Stressful events, disrupted sleep, substances, and some medications can precipitate or complicate episodes in vulnerable individuals. A trigger should be distinguished from the complete explanation for the disorder. Substance use may cause mood symptoms independently, intensify an episode, or coexist with bipolar disorder. It is essential to assess such possibilities rather than assume every period of activation is a bipolar episode. VA/DoD
Family relationships, social adversity, and access to healthcare can influence symptom recognition and outcome. These factors should be examined as part of a comprehensive formulation, while avoiding blame directed at the individual or family.
Prevalence and Age of Onset
The prevalence of bipolar disorders varies according to country, diagnostic criteria, study period, and whether broader spectrum presentations are included. The NIMH reports a past-year estimate of 2.8% among U.S. adults, derived from the National Comorbidity Survey Replication conducted in 2001–2003. It is a historical survey statistic rather than a real-time 2026 prevalence measure. NIMH bipolar statistics
Symptoms often become recognizable in adolescence or early adulthood, although presentation and recognition may occur at other ages. Assessment must take account of developmental stage, cultural context, possible medical explanations, and how symptoms affect daily functioning. Epidemiologic averages cannot predict the illness course of a particular person. WHO
How Is Bipolar Disorder Diagnosed?
Diagnosis begins with a careful clinical history rather than a blood test, scan, or internet questionnaire. A qualified mental health clinician evaluates whether periods of altered mood, energy, activity, and sleep form episodes meeting the relevant criteria. The assessment considers duration; severity; change from baseline; functioning; hallucinations or delusions; depressive history; prior treatment; family history; medications; and alcohol or other substance use. Medical and neurological explanations must also be considered. VA/DoD (2023) | NICE CG185
A clinician may ask someone to reconstruct a timeline of elevated, irritable, and depressive periods. Medical records and, when appropriate and consensual, accounts from trusted people can add information about episodes the person did not identify as unusual. A physical examination and selected laboratory tests may help evaluate thyroid disease, medication effects, or other possible causes and establish a baseline for safe treatment. Laboratory testing does not itself establish bipolar disorder.
Diagnosis may require follow-up across time, particularly when an initial presentation consists entirely of depression. Earlier hypomania may have felt pleasant, may have been forgotten, or may have been confused with stress-related insomnia or increased productivity. The working diagnosis can be refined when new information becomes available. NIMH
Do screening tools diagnose bipolar disorder?
No. Screening questionnaires, including the Mood Disorder Questionnaire (MDQ), can identify experiences that warrant clinical discussion, but they are not substitutes for a structured diagnostic assessment. Sensitivity and specificity depend on setting and population, and both false positives and false negatives occur. A positive screen requires clarification of actual episodes and other possible explanations. A negative screen cannot independently rule out bipolar disorder. Screening should inform a conversation, not justify beginning or discontinuing medication. VA/DoD
What should a person bring to an assessment?
An approximate chronology of mood episodes can be particularly useful: changes in sleep and energy, depressive symptoms, work and relationship consequences, impulsive decisions, prior emergency visits, response to medication, family history, and substance use. Notes about symptoms are helpful even when dates are uncertain. Someone who feels unsafe or is developing severe mania or psychosis needs more immediate assessment than a routine appointment.
Differential Diagnosis: Conditions That Can Resemble Bipolar Disorder
Major depressive disorder can look similar to bipolar depression during a single depressive episode. Lifetime mania or hypomania changes the diagnostic interpretation and may substantially change treatment. A clinician must not infer bipolar disorder solely from recurrent depression, irritability, or an antidepressant-related change without examining the full circumstances. NIMH
Borderline personality disorder can involve rapid changes in feelings and behavior, while attention-deficit/hyperactivity disorder can include persistent distractibility, impulsivity, and talkativeness. Clinicians examine the course: relatively enduring patterns and context-dependent responses versus sustained, distinct changes in mood and energy from baseline. Conditions may coexist, so differential diagnosis is not always a simple either-or decision. NICE CG185
Anxiety disorders, obsessive-compulsive disorder, sleep disorders, trauma-related problems, and substance-related conditions can include agitation, intrusive thoughts, sleep disruption, or impulsive behavior. Their characteristic mechanisms and timelines matter. For a precise discussion of intrusive thoughts and bipolar episodes, see OCD vs Bipolar Disorder. For true co-occurrence, see OCD and Bipolar Disorder.
The differential also includes substance- or medication-induced mood changes, thyroid and neurological disorders, and psychotic disorders. The temporal relationship between psychosis and mood episodes can help distinguish bipolar disorder from schizophrenia or schizoaffective disorder. A history of elevated mood and reduced sleep must therefore be interpreted together with medical exposure, functioning, and observed course. VA/DoD
Treatment of Bipolar Disorder
Bipolar treatment is organized around the current episode and the long-term course. Acute mania, bipolar depression, and maintenance have overlapping but different evidence bases. The diagnosis, past response, treatment safety, medical comorbidity, reproductive considerations, patient preferences, and availability of follow-up influence decisions. Treatment often combines medication, psychoeducation, other appropriate psychotherapy, and support for sleep and daily routines. VA/DoD | CANMAT/ISBD
Treatment of acute mania
Acute mania can require rapid specialist assessment. Antipsychotic medications, mood stabilizers such as lithium, or combinations are used according to illness severity, individual history, and safety. Severe episodes involving psychosis, marked impairment, extreme agitation, or danger may require inpatient care. Stabilizing sleep and reducing immediate exposure to financial or interpersonal harm may be part of a comprehensive plan. NICE CG185
The evidence and recommendations for each medicine differ. Lamotrigine, for example, is not recommended to treat acute mania. If someone is already taking prescribed treatment, medication adjustments should be made by the treating clinician after review of interactions and side effects. NICE CG185
Treatment of bipolar depression
Bipolar depression calls for its own treatment choices. Depending on subtype, local indications, earlier response, clinical circumstances, and guideline, treatments considered may include quetiapine, lithium, lamotrigine, lurasidone-containing regimens, and other appropriately selected medications. Their place in acute bipolar depression and maintenance differs. In particular, a medication that prevents depressive recurrence cannot automatically be assumed to provide rapid relief in an acute episode. CANMAT/ISBD | VA/DoD
Antidepressant monotherapy is generally discouraged in bipolar I depression because of concerns about mood switching and uncertain benefit. Adjunctive antidepressants may be considered selectively under clinical supervision, with caution around mixed features, rapid cycling, and a history of switches. Bipolar II recommendations can differ in selected cases, but the existence of such exceptions does not support independent medication changes. CANMAT/ISBD
Maintenance treatment and prevention of recurrence
Maintenance care aims to prevent future episodes, reduce their severity, and preserve everyday functioning. Lithium has an important evidence base in long-term management. Selected antipsychotics, lamotrigine, and other treatments also have roles, depending on the diagnosis and the types of episodes being prevented. Periodic review evaluates effectiveness, physical health, side effects, adherence, quality of life, and the individual's recovery priorities. NICE CG185 | CANMAT/ISBD
A relapse-prevention plan can record early signs of mania or depression, preferred clinical contacts, strategies for protecting sleep, and practical steps to reduce risks during an emerging episode. It should be made with the person rather than simply imposed. Stable periods create an opportunity to examine whether treatment is tolerable and sustainable.
Mood Stabilizers, Antipsychotics, and Medication Safety
Lithium: benefits and monitoring
Lithium is used in several phases of bipolar care and is a major maintenance option. It has a narrow therapeutic range, making blood-level monitoring essential. Kidney function, thyroid function, calcium, and relevant health indicators are assessed before and during treatment. Dehydration, substantial changes in salt and fluid balance, and interactions with certain medications—including some diuretics, ACE inhibitors, and nonsteroidal anti-inflammatory drugs—can increase toxicity risk. Monitoring schedules and target levels must be individualized by the prescriber. NICE CG185
Possible adverse effects include tremor, thirst, frequent urination, gastrointestinal symptoms, thyroid changes, and kidney-related complications. Severe vomiting, worsening tremor, unsteady gait, confusion, or profound weakness can indicate toxicity and justify urgent medical assessment. Pregnancy planning and medical illness require additional review. Patients should never adjust or abruptly stop lithium based solely on general online advice. NICE CG185
Lamotrigine: depressive prevention and skin safety
Lamotrigine has roles in bipolar depression and prevention of depressive episodes, but it is not an acute antimanic treatment. Treatment is introduced gradually because serious skin reactions, including Stevens–Johnson syndrome, can occur. New rash during initiation or dose escalation requires prompt medical advice, especially with fever, mucosal involvement, or systemic illness. Valproate can increase lamotrigine exposure and necessitates clinician-managed dosing adjustments. NICE CG185
Valproate: effectiveness and reproductive risks
Valproate or divalproex may be used for certain manic presentations, but it has serious pregnancy and reproductive risks. Prenatal exposure can result in congenital malformations and adverse neurodevelopmental outcomes. National prescribing restrictions differ, and treatment requires careful reproductive counseling and specialist risk assessment. Monitoring can involve liver function, blood counts, weight, interactions, and tolerability. A person who is pregnant or may become pregnant should seek prompt specialist discussion rather than abruptly discontinuing an established prescription. NICE CG185, updated 2025
Antipsychotics: agent-specific benefits and adverse effects
Some second-generation antipsychotics are indicated for acute mania, some for bipolar depression, and some for maintenance. They should not be treated as interchangeable. Clinicians may monitor body weight, blood pressure, glucose or A1c, lipids, sedation, abnormal movements, cardiovascular risks, and individual adverse effects. Choice of agent should consider medical history and the intended treatment phase as well as symptom relief. VA/DoD | NICE CG185
Antidepressants and medication interactions
Antidepressants can be appropriate in carefully selected circumstances, but bipolar-specific assessment is essential because antidepressant-associated mood switching or activation can be clinically consequential. The evidence and risks depend on the episode, bipolar subtype, drug, and concurrent mood-stabilizing treatment. Any signs of newly reduced need for sleep, accelerating activity, unusual agitation, or risk-taking during medication changes warrant contact with the prescriber. CANMAT/ISBD
Prescribed medicines, over-the-counter drugs, alcohol, and other substances should be reviewed together. Abruptly stopping psychiatric medicines can create withdrawal symptoms, instability, or recurrence risks. Decisions about initiation, changes, tapering, and monitoring belong in an individualized clinical plan.
Psychotherapy and Psychoeducation
Psychotherapy is an important part of comprehensive bipolar care, commonly alongside medication. Structured psychoeducation helps people understand episode patterns, medication roles, warning signs, sleep disruption, substance effects, and collaborative relapse planning. Cognitive behavioral therapy can address depressive symptoms, coping, and practical difficulties. Family-focused therapy can strengthen communication and shared recognition of early signs when family participation is welcomed. Interpersonal and social rhythm therapy targets daily routines and interpersonal changes associated with rhythm disruption. NIMH
A systematic review and component network meta-analysis of randomized clinical trials found that several structured adjunctive psychological interventions were associated with lower recurrence risk than control conditions, although results differed across modalities, populations, and outcomes. This supports appropriately selected psychosocial care without assuming that one form of therapy alone is sufficient for acute severe mania or for all maintenance situations. Miklowitz and colleagues, JAMA Psychiatry
Psychotherapy can also address stigma, grief about disrupted plans, work or relationship difficulties, anxiety, and adherence concerns. Treatment should be adapted to the current mood state, personal circumstances, access barriers, and values. A therapeutic relationship that supports collaboration is especially important when the illness has previously involved episodes of impaired judgment.
Electroconvulsive Therapy and Specialist Care
Electroconvulsive therapy (ECT) can be considered for severe, treatment-resistant, or clinically urgent bipolar episodes, including certain presentations involving catatonia or severe depression. It is delivered in a specialist medical setting with anesthesia and systematic evaluation of benefits and risks. The evidence supporting other neuromodulation approaches varies by technique and phase; findings from unipolar depression cannot automatically be transferred to bipolar illness. NICE CG185 | NIMH
Complex or treatment-resistant cases may call for reassessing diagnosis, previous treatment exposure, adherence challenges, substance use, co-occurring illnesses, medication interactions, and access to evidence-based psychosocial interventions. A new plan is best informed by careful review rather than simply adding medications without clear targets.
Living With Bipolar Disorder
Bipolar disorder can be compatible with meaningful work, supportive relationships, and independent decision-making. Recovery plans benefit from attention to personal goals, predictable care access, reasonable adjustments at work or school, and treatment of physical health conditions. A period of remission is an opportunity to build resilience and plans for future episodes, not a reason to doubt the reality of previous illness. WHO
Regular sleep-wake patterns can support stability. Practical strategies may include consistent bedtimes, identifying the early signs of reduced need for sleep, limiting high-risk decisions when activation escalates, attending follow-up visits, and noting medication side effects. Mood tracking can be useful when it is manageable and reviewed in context; tracking every emotional change is not necessary to establish a clinical diagnosis. NICE CG185
A written plan may list a trusted person's contact information, warning signs particular to the individual, where to seek clinical evaluation, and how to reduce risks involving spending, driving, or substance use during episodes. It should respect autonomy, privacy, and preferences. Difficult periods may require more support; stable periods allow the person to define what that support should look like.
Supporting a family member, partner, or friend
Trusted people can help by recognizing changes in sleep and activation, communicating calmly, encouraging access to assessment, and offering concrete assistance during depression. Where invited, participation in family psychoeducation or a shared relapse plan can improve communication. Safety takes priority during severe mania, psychosis, or suicidal crises. Supporters also need boundaries and their own access to help. NIMH | Miklowitz et al.
A diagnosis should not be used to dismiss someone's ordinary opinions, emotions, or decisions. When there is concern about an episode, describe observable changes and their impact, invite clinical discussion, and focus on the person's safety and stated goals.
Children, Older Adults, and Pregnancy
Children and adolescents require developmentally informed specialist assessment. Irritability, impulsivity, attention problems, high activity, and sleep changes may have multiple explanations. The clinician looks for distinct episodes, developmental baseline, impairment, and differential diagnoses. Evidence from adults cannot be automatically generalized to young people. Treatment needs age-appropriate safety and family considerations. NICE CG185
Later-life presentation requires attention to physical illness, cognitive changes, neurological conditions, kidney function, medication interactions, fall risk, and other factors affecting tolerability. New mania-like symptoms in an older adult warrant a thorough medical evaluation rather than assuming an established bipolar illness.
Pregnancy planning, pregnancy, and the postpartum period involve particularly important benefit-risk discussions. Some medicines, especially valproate, carry serious fetal risks; abrupt loss of effective treatment can also increase relapse risk. Postpartum mood episodes can be severe and may require rapid intervention. Coordinated psychiatric and obstetric care can address medication selection, monitoring, sleep, and family support. Advice must be individualized, including when breastfeeding or considering medication changes. NICE CG185
Bipolar Disorder and Suicide Risk
Bipolar disorders are associated with elevated risk of suicidal thoughts and behavior, particularly during severe depression, mixed symptoms, some transitions between episodes, and other high-risk situations. Risk is individual and changes over time. Assessment includes intent, plans, means, past behavior, agitation, substance use, protective relationships, and access to urgent care. A diagnosis alone does not determine whether any specific person is currently suicidal. WHO | VA/DoD
An emergency assessment is appropriate when someone has suicidal intent or a plan; develops psychosis with unsafe behavior; has severe mania with greatly impaired judgment; becomes unable to attend to basic needs; or shows signs of serious medication toxicity. In immediate danger, contact local emergency services or go to an emergency department. In the United States, the 988 Suicide & Crisis Lifeline is available by call or text. Elsewhere, use local emergency and crisis resources. CDC crisis support
For a routine clinical discussion, it is useful to describe the onset and sequence of the changes, sleep, medicines, substances, and safety concerns. When danger is immediate, an urgent assessment should take precedence over completing a mood diary or internet screening test.
Common Misconceptions
“Bipolar disorder means changing moods several times a day.”
Diagnostic mood episodes are sustained changes of mood and activation that meet clinical duration and severity requirements. Rapid cycling means multiple qualifying episodes across a year, not ordinary emotional variation within a day. NIMH
“Bipolar II is always less severe.”
Bipolar II excludes full mania but can involve severe, recurring depression, impaired functioning, and substantial risk. The distinction describes episode type, not an overall ranking of human suffering or clinical need. CANMAT/ISBD
“People with bipolar disorder cannot live stable lives.”
Many people experience sustained remission and meaningful recovery. Long-term follow-up, appropriate treatment, reliable support, and individualized relapse plans can help maintain functioning. WHO
“A positive bipolar screening test confirms the diagnosis.”
A screening result only identifies the need for further assessment. Clinical diagnosis requires evaluation of the entire episode history, impairment, alternatives, medication effects, and sometimes information from people who observed the changes. VA/DoD
“The same treatment works for every mood episode.”
The evidence for acute mania, bipolar depression, and prevention of recurrence differs. Medication choice and safety monitoring must reflect diagnosis, current episode, history, and patient preferences. NICE CG185
Frequently Asked Questions
What are the first signs of bipolar disorder?
There is no universal first symptom. Some people first experience depression, while others have periods of elevated activity, reduced need for sleep, or irritability. A distinct cluster of changes sustained over time is more informative than any isolated symptom. Clinical assessment is appropriate when the changes substantially alter usual functioning. NIMH
Can bipolar disorder occur without a depressive episode?
A major depressive episode is not required for bipolar I disorder, which is defined by at least one manic episode. Bipolar II requires both a hypomanic episode and a major depressive episode. The clinician also assesses alternative explanations. NIMH
Can someone have bipolar disorder and ADHD or OCD?
Yes. Co-occurring conditions are possible, and the assessment should establish which symptoms belong to which condition, whether bipolar mood episodes are present, and how treatment might affect both. See the detailed OCD and Bipolar Disorder guide for that specific overlap.
Is bipolar disorder hereditary?
Genetic vulnerability is important, and family history increases risk, but inheritance is not deterministic. Many family members of affected people will not develop the disorder. No routine genetic test establishes bipolar disorder in an individual. NIMH
Can bipolar disorder be cured?
It is generally approached as a recurrent or long-term condition that can often be managed effectively. Treatment may produce extended stability and substantial functional recovery. Individual outcomes vary; a claim of a guaranteed permanent cure is unsupported. WHO
Will everyone with bipolar disorder need medication for life?
Long-term medication is often recommended because episodes may recur after apparently stable periods. The plan is reviewed in light of diagnosis, prior episodes, effectiveness, adverse effects, and preferences. Decisions about tapering or changing treatment should be made with a prescriber and an appropriate monitoring strategy. NICE CG185
Can mania occur without feeling happy?
Yes. Mania may present primarily with irritability, anger, agitation, or expansive activity rather than euphoria. The diagnostic assessment evaluates activation, associated symptoms, duration, and consequences. NIMH
What information should I share with a doctor?
Describe approximate episode dates, sleep and energy changes, major depressive periods, unusual spending or activity, functional effects, family observations, previous prescriptions, substances, and medical problems. Include safety concerns and any recent major changes. A written timeline is useful but not required for care. VA/DoD
Related Articles
References
Centers for Disease Control and Prevention. (n.d.). Mental health and crisis support resources. CDC.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009.
Miklowitz, D. J., et al. (2021). Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiatry. Journal article.
National Institute for Health and Care Excellence. (2014; updated 2025). Bipolar disorder: Assessment and management (CG185). Recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. Clinical overview.
National Institute of Mental Health. (n.d.). Bipolar disorder statistics. Epidemiological overview.
Substance Abuse and Mental Health Services Administration. (2016). DSM-IV to DSM-5 hypomania criteria comparison. NCBI Bookshelf.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. Official guideline.
World Health Organization. (n.d.). Bipolar disorder. WHO fact sheet.